(Q45422129)

English

Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

author name string

Richard J Noel

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Anil Kumar

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

28 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

346

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

127-138

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Injection drug use and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Permeability of the blood-brain barrier to HIV-1 Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Morphine induces sepsis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 tat transcriptional activity is regulated by acetylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Morphine increases susceptibility to oral Salmonella typhimurium infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Continued drug use and other cofactors for progression to AIDS among injecting drug users.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Role of nitric oxide in HIV-1 infection: friend or foe?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

Molecular basis for interactions of HIV and drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

based on heuristic

inferred from DOI database lookup

SIV infection of macaques--modeling the progression to AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.10.026

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45422129&oldid=2076915954"